RxDoctor Payments Data

Angela Sun

Clinical Genetics (M.D.) · Cincinnati, OHNPI 1760652267

Payments from drug & device makers

What this record shows

This record is dominated by consulting fees: $2,640 of the $2,969 with a category attached, or 88.9%. Takeda Pharmaceuticals U.S.A., Inc. accounts for 90.7% of it on its own, with 3 other manufacturers making up the rest. Reporting peaked in 2020 at $2,694 and has fallen 99.0% since, to $27 in 2025.

$2,969in general payments, 2019–2025

Across 8 payments — averaging $371.09 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Takeda Pharmaceuticals U.S.A., Inc.$3K
  • Sanofi$218
  • Ultragenyx Pharmaceutical Inc.$30
  • PTC Therapeutics, Inc.$27
$547,738in research payments, 2019–2025

Across 76 payments — averaging $7207.08 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Takeda Pharmaceuticals U.S.A., Inc.$279K
  • Biomarin Pharmaceutical Inc.$165K
  • Ultragenyx Pharmaceutical Inc.$71K
  • Hikma Pharmaceuticals USA$25K
  • Shire North American Group Inc$8K

What the payments were for

  • Consulting fees$2,64089%
  • Travel & lodging$321%
  • Food & beverage$2619%
  • Education$361%

General payments by program year

19
20
21
23
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$2,969 in reported general payments places this provider in the 75th percentile of 42 clinical genetics (m.d.) providers in Ohio.

See all clinical genetics (m.d.) providers in Ohio →

Other clinical genetics (m.d.) in Cincinnati

See the full list for Ohio →

Where these figures come from

Is this you, or does something look wrong? →